James Strenner, talks to FBNC about GSK’s progress

In the last 18 months since Jan 2015, we are focusing on some critical areas that differentiate us as an organization with the industry. I probably say that the biggest differentiate us is we are incredibly focused on putting the patient at the heart of everything we do, and that impact every single decision that we make, tangibly we change the way that we drive our business model…